Answers are grounded in this paper and cite their sources.
The ability of the carcinogenic mycotoxin ochratoxin A (OTA) to react with reduced glutathione (GSH) has been assessed using electrospray ionization (ES)-MS techniques. On the basis of the assumption that OTA undergoes biotransformation into the reactive quinone species OTQ (6), a synthetic sample of the reduced form of OTQ (6), hydroquinone OTHQ (5), was prepared and photoreacted with 6 M equiv of GSH to yield an authentic sample of the conjugate 8 that was definitively identified by mass spectrometry, UV-vis spectroscopy and NMR. With the authentic sample of 8 in hand, it was demonstrated that the same conjugate is produced from reaction of 100 microM OTA (1) in the presence of 5 mM GSH following incubation for 1 h with either horseradish peroxidase (HRP)/H(2)O(2), rat liver microsomes (RLM)/NADPH or free Fe(II). In each of these oxidative systems the conjugate 8 was generated in less than 1% yield and the parent OTA molecule is poorly metabolized. Comparison of the peak area ratio of the conjugate 8 to that for the hydroxyOTA metabolite from the RLM/NADPH system implied that the conjugate was produced at a rate of approximately 1-3 pmol min(-)(1) (mg of protein)(-)(1). These studies are the first to demonstrate that OTA undergoes biotransformation to a reactive intermediate [OTQ (6)] that covalently reacts with GSH to yield the conjugate 8. The biological implications of the reactivity of OTA toward GSH are discussed.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: